• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Promoting Treatment Adherence in nAMD and DME


Experts discuss the use of steroids, particularly in the context of diabetic macular edema (DME). The inflammatory nature of DME reveals the effectiveness of steroids, especially in cases where persistent fluid remains despite anti-VEGF treatment.


Experts conclude their discussion reflecting on recent therapeutic advancements and novel approaches on the horizon. As the use of longer durability agents increases, there's optimism that patient adherence to treatment will improve, potentially leading to better real-world outcomes compared to clinical trials. Educating patients about the importance of regular follow-ups and the ongoing nature of treatment is crucial for maintaining adherence. Visual aids like OCT scans can motivate patients by showing the reduction of fluid and improvement in their condition over time. Ultimately, fostering patient buy-in early on and providing ongoing support are key to maximizing treatment effectiveness and preserving vision in conditions like neovascular AMD and diabetic macular edema.

This summary was AI-generated and edited for clarity.

Related Videos
Video 5 - "Evolving Role of Steroids and Laser In DME"
Video 3 - "Treating a DME Patient Lost to Follow-Up with a Highly Durable Agent"
Video 2 - "A Case of Neovascular AMD with Persistent Subretinal Fluid"
Video 1 - "A Case of Neovascular AMD With Treatment-Resistant Pigment Epithelium Detachment"
© 2024 MJH Life Sciences

All rights reserved.